Executive Profile

Peter Barrett Ph.D. President , Autism Consortium

Age	Total Calculated Compensation	This person is connected to 12 Board Members in 12 different organizations across 17 different industries. See Board Relationships
59	--

Background

Dr. Peter Barrett, Ph.D., serves as a Partner of Atlas Venture L.P. Dr. Barrett joined Atlas Venture in 2002 and is a part of the life sciences group and focuses on investments in therapeutics and medical technologies that significantly change the medical management of patien. He serves as Adjunct Professor at the Barnett Institute. Dr. Barrett was a Co-Founder of Celera Genomics and served as its Executive Vice President and Chief Business Officer. He helped launch ... Celera as a publicly traded entity in 1999. He led Celera’s strategic alliances and acquisitions, and participated in raising nearly $1 billion in capital for the company. He served as Vice President of Corporate Planning and Business Development at Applera Corp. Dr. Barrett led Celera’s strategic alliances and acquisitions and participated in raising nearly $1 billion in capital for the company. He served at The Perkin-Elmer Corporation from 1980 to 1990 and served as its Vice President of Corporate Planning and Business Development and as an Executive Vice President of the Applied Biosystems Division. During his tenure, he co-founded Celera Genomics with Dr. J. Craig Venter and the Applera Corporation management team and expanded the life science business units through a series of licensing agreements, partnerships, and acquisitions including Applied Biosystems, Tropix, Molecular Informatics, PerSeptive Biosystems, and Genscope. In addition, he incubated Stromedix in Atlas’ offices and was actively involved in building both Alnylam and Momenta Pharmaceuticals. He leverages his background in corporate business development to provide strategic and negotiating guidance to his portfolio; he was instrumental in the sales of Stromedix to Biogen and Novamed to SciClone Pharmaceuticals. He served as Executive Vice President of Applied Biosystems Division at Perkin-Elmer. He served as the Acting Chief Executive Officer of Zafgen. He serves as Chairman of Ivrea Pharmaceuticals, Inc., Molecular Biometrics, Inc. and Zafgen, Inc. He served as the Chairman of Momenta Pharmaceuticals Inc. from June 2005 to 2008. He served as Chairman of the Board of the Analytical and Life Science System Association. He held senior management positions at PerkinElmer, most recently serving as Vice President, Corporate Planning and Business Development. During his tenure, he expanded the life science business units through a series of licensing agreements, partnerships, and acquisitions. Dr. Barrett has been a Director of PerkinElmer Inc. since February 1, 2012. He has been a Director of SciClone Pharmaceuticals, Inc. since April 2011. He serves as a Director of Aureon Biosciences, Inc. He serves as a Director of Sirion Therapeutics, Inc. He serves as a Director of Aureon Laboratories, JenaValve Technology GmbH, Molecular Biometrics, IVREA Pharmaceuticals, InfaCare Pharmaceutical Corporation, Stromedix, Inc., Vitae Pharmaceuticals, Inc. He served on the board of Sirion Therapeutics and Archemix since March 2002. Dr. Barrett's served as a Director of HuBit Genomix, Genecore, Roche Strategic Alliance, and Sciex Joint Venture. He served as a Director of Alnylam Pharmaceuticals, Inc. from July 2002 to June 01, 2007. He served as a Director of Akela Pharma Inc. since December 2005. He serves as the Vice Chairman of the Advisory Council of the Barnett Institute of Chemical and Biological Analysis at Northeastern University.He served as a Director of Helicos BioSciences Corporation from 2003 to August 24, 2012. Dr. Barrett also serves as the President of the Autism Consortium, is a member of the research council at Boston Children’s Hospital, and as a member of the Partners Healthcare Research Accelerator Program. He received his B.Sc. degree in Chemistry from Lowell Technological Institute (now known as the University of Massachusetts, Lowell) and his Ph.D. degree in Analytical Chemistry from Northeastern University. He also completed Harvard Business School’s Management Development Program.

Corporate Headquarters -- --, -- -- United States Phone: -- Fax: -- Board Members Memberships Former Director HuBit Genomix Inc. Director InfaCare Pharmaceutical Corporation Director Vitae Pharmaceuticals, Inc. Director Aureon Biosciences, Inc. Chairman Ivrea Pharmaceuticals, Inc. Chairman Zafgen, Inc. Director Stromedix, Inc. Director JenaValve Technology GmbH Director Sirion Therapeutics, Inc. Chairman Molecular Biometrics, Inc. 2002-Present Lead Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee Archemix Corp. 2002-2007 Former Director Alnylam Pharmaceuticals, Inc. 2003-2008 Former Chairman, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee Momenta Pharmaceuticals Inc. 2003-2012 Former Director, Member of Compensation Committee and Member of Audit Committee Helicos BioSciences Corporation 2005-N/A Former Director and Member of Compensation Committee Akela Pharma Inc. 2011-Present Director, Member of Business Development Committee and Member of Compensation Committee SciClone Pharmaceuticals, Inc. 2012-Present Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee PerkinElmer Inc. Education Unknown/Other Education Harvard Business School PhD Northeastern University BS University of Massachusetts Lowell Other Affiliations Atlas Venture L.P. PerkinElmer Inc. SciClone Pharmaceuticals, Inc. Celera Corporation Applied Biosystems, Inc. HuBit Genomix Inc. Archemix Corp. Akela Pharma Inc. Harvard Business School Applera Corp., Prior to Spin-off of Celera Corporation InfaCare Pharmaceutical Corporation Vitae Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. Aureon Biosciences, Inc. Atlas Venture Fund VI, L.P. Northeastern University University Of Massachusetts Momenta Pharmaceuticals Inc. Francis College of Engineering University of Massachusetts Lowell Helicos BioSciences Corporation Ivrea Pharmaceuticals, Inc. Atlas Venture Fund VII, L.P. Zafgen, Inc. Stromedix, Inc. JenaValve Technology GmbH Sirion Therapeutics, Inc. Molecular Biometrics, Inc.

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.